Two patients with the Wiskott-Aldrich syndrome had complete donor lymphoid and hematopoietic engraftment after successful allogeneic bone-marrow transplantation. One patient had had only a temporary donor T-lymphocyte graft after a previous transplantation, for which he had been prepared with cytarabine and cyclophosphamide; the patient's own T lymphocytes returned six months later. A repeat transplant, for which the patient was prepared with anti-human thymocyte serum, total-body irradiation and procarbazine, resulted in complete donor engraftment. The second patient underwent a successful transplantation after similar preparation, except that procarbazine was omitted. At 11 and five months after transplantation both had normal hematopoiesis and no evidence of graft-versus-host disease. This treatment of the Wiskott-Aldrich syndrome may be a model for the correction of other genetically determined immune and hematologic bone-marrow disorders.
This article has been cited by other articles:
Ozsahin, H., Cavazzana-Calvo, M., Notarangelo, L. D., Schulz, A., Thrasher, A. J., Mazzolari, E., Slatter, M. A., Le Deist, F., Blanche, S., Veys, P., Fasth, A., Bredius, R., Sedlacek, P., Wulffraat, N., Ortega, J., Heilmann, C., O'Meara, A., Wachowiak, J., Kalwak, K., Matthes-Martin, S., Gungor, T., Ikinciogullari, A., Landais, P., Cant, A. J., Friedrich, W., Fischer, A.
(2008). Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood
111: 439-445
[Abstract][Full Text]
Bernabeu, E., Josa, M., Nomdedeu, B., Ramirez, J., Garcia-Valentin, A., Mestres, C. A., Mulet, J.
(2007). One-Step Surgical Approach of a Thoracic Aortic Aneurysm in Wiskott-Aldrich Syndrome. Ann. Thorac. Surg.
83: 1537-1538
[Abstract][Full Text]
Klein, C., Nguyen, D., Liu, C.-H., Mizoguchi, A., Bhan, A. K., Miki, H., Takenawa, T., Rosen, F. S., Alt, F. W., Mulligan, R. C., Snapper, S. B.
(2003). Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood
101: 2159-2166
[Abstract][Full Text]
Rawlings, S. L., Crooks, G. M., Bockstoce, D., Barsky, L. W., Parkman, R., Weinberg, K. I.
(1999). Spontaneous Apoptosis in Lymphocytes From Patients With Wiskott-Aldrich Syndrome: Correlation of Accelerated Cell Death and Attenuated Bcl-2 Expression. Blood
94: 3872-3882
[Abstract][Full Text]
Neipp, M., Zorina, T., Domenick, M. A., Exner, B. G., Ildstad, S. T.
(1998). Effect of FLT3 Ligand and Granulocyte Colony-Stimulating Factor on Expansion and Mobilization of Facilitating Cells and Hematopoietic Stem Cells in Mice: Kinetics and Repopulating Potential. Blood
92: 3177-3188
[Abstract][Full Text]
Gallego, M. D., Santamaria, M., Pena, J., Molina, I. J.
(1997). Defective Actin Reorganization and Polymerization of Wiskott-Aldrich T Cells in Response to CD3-Mediated Stimulation. Blood
90: 3089-3097
[Abstract][Full Text]
van Son, J. A. M., O'Marcaigh, A. S., Edwards, W. D., Julsrud, P. R., Danielson, G. K.
(1995). Successful Resection of Thoracic Aortic Aneurysms in Wiskott-Aldrich Syndrome. Ann. Thorac. Surg.
60: 685-687
[Abstract][Full Text]
Rosen, F. S., Cooper, M. D., Wedgwood, R. J.P.
(1995). The Primary Immunodeficiencies. NEJM
333: 431-440
[Full Text]
Armitage, J. O.
(1994). Bone Marrow Transplantation. NEJM
330: 827-838
[Full Text]
Dubiel, A., Szczerbinski, T., Kurtyka, Z., Kowalczyk, D.
(1990). Wiskott-Aldrich Syndrome: A Case Report. CLIN PEDIATR
29: 434-437
[Abstract]
Parkman, R
(1986). The application of bone marrow transplantation to the treatment of genetic diseases. Science
232: 1373-1378
[Abstract]
James, W. D., Odom, R. B.
(1983). Graft-v-Host Disease. Arch Dermatol
119: 683-689
[Abstract]
